Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Lexicon Pharmaceuticals (LXRX.US)$ Lexicon Pharmaceuticals Announces Phase 3 Trial Results For Sotagliflozin In Insulin-Treated Type 2 Diabetes, Showing Improved Time-In-Range And Glucose Variability; Data To Be Presented At European Association For The Study Of Diabetes Annual Meeting On September 12th
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
Translate
Report
4634 Views
3576Followers
23Following
53KVisitors
Follow